Product Information
LISDEXAMFETAMINE 30 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $3.0366 per EA under NDC 43547060410. Its NADAC has been published 144 times since Sep 27, 2023.
Strength
30 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547060410
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA216266On Market Since
8/26/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has been published 144 times since Sep 27, 2023, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0366 per EA |
|---|---|
| All-time high | $6.5077 (Apr 10, 2024) |
| All-time low | $2.9584 (Mar 18, 2026) |
| 52-week high | $3.9018 |
| 52-week low | $2.9584 |
| Median price | $3.9441 |
| Average price | $4.1661 |
| Largest weekly change | +59.1% (Jun 19, 2024) |
| Weeks tracked | 144 |
| Tracking since | Sep 27, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Lisdexamfetamine dimesylate capsules market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $3.0366 per EA (NDC 43547060410), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has declined 14.8%. It has been tracked across 144 weekly CMS publications since Sep 27, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG CAPSULE?
Since Sep 27, 2023, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has ranged from a low of $2.9584 (Mar 18, 2026) to a high of $6.5077 (Apr 10, 2024), with a median of $3.9441 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LISDEXAMFETAMINE 30 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures LISDEXAMFETAMINE 30 MG CAPSULE?
LISDEXAMFETAMINE 30 MG CAPSULE (NDC 43547060410) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification